Norris Perne & French’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
963
+10
+1% +$10.2K 0.05% 77
2026
Q1
$877K Buy
953
+132
+16% +$134K 0.04% 84
2025
Q4
$883K Buy
821
+225
+38% +$215K 0.06% 87
2025
Q3
$455K Buy
596
+130
+28% +$96.7K 0.03% 106
2025
Q2
$363K Hold
466
– – 0.03% 112
2025
Q1
$385K Buy
466
+20
+4% +$16.6K 0.03% 107
2024
Q4
$344K Hold
446
– – 0.02% 110
2024
Q3
$395K Hold
446
– – 0.03% 107
2024
Q2
$404K Buy
446
+38
+9% +$30.4K 0.03% 104
2024
Q1
$318K Buy
+408
New +$290K 0.02% 114
2023
Q4
– Sell
-427
Closed -$229K – 137
2023
Q3
$229K Buy
+427
New +$220K 0.02% 118

Other funds holding LLY

Norris Perne & French's LLY Position: Q2 2026 in Review

Norris Perne & French increased its Eli Lilly (LLY) stake by 1% in Q2 2026, buying an estimated $10.2K and bringing the position to 963 shares worth $1.15M. The position accounts for 0.05% of the portfolio, ranked #77.

Norris Perne & French first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Norris Perne & French held 963 shares of Eli Lilly worth $1.15M as of Q2 2026.
  • Norris Perne & French bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.05% of Norris Perne & French's portfolio in Q2 2026, its #77 holding.
  • Norris Perne & French first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Norris Perne & French's 13F filing for Q2 2026, filed 21 Jul 2026.